Neue Suche | Kongressdetail
mail
Druckansicht
 
 

ADC and Radiopharmaceuticals Pharma and Biotech Partnering Summit

Evvnt Promotion / evvnt
Archiv
-
09.09.2024 - 10.09.2024  Revere Hotel Boston Common, 200 Stuart Street, 02116 Boston, Massachusetts, USA
Time: 9:00 AM - 5:00 PM
 
Kongressthemen
Major moves in the pharma and biotech partnering are reshaping the landscape. With AbbVie's acquisition of ImmunoGen leading the charge in 2023, and Merck's licensing deal with Daiichi reaching unprecedented heights across three ADC programs, the market frenzy surrounding ADCs has never been hotter.

Even Eli Lilly's acquisition of Mablink, despite lacking clinical programs, underscores the feverish pace of activity in the field, breaking traditional pharma partnering trends.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
URL:
Brochure: https://go.evvnt.com/2481194-3?pid=4832

Speakers: Adrianne Wong, Director, Oncology Search and Evaluation, Global Business Development, Daiichi Sankyo, Albert Hsia, Executive Director, Business Development, Merck, and more
 

Anfragen und Anmeldung:

https://go.evvnt.com/2481194-2?pid=4832
Frau Karina Bikerniece
 
Kategorien
Allgemeinmedizin
Sprache
Englisch
Kongressgebühr
Two Day Attendance and Access to Partnering Portal - Biotech, Pharma and Investors: USD 2999.00, Two Day Attendance and Access to Partnering Portal - Academics: USD 2399.00
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

Alumni Club Medizinische Universität WienEuropean Health Forum GasteinnewTreeSwiss Tropical and Public Health InstituteAnästhesie in Entwicklungsländern e. V.Österreichische Gesellschaft für Public HealthÖsterreichisches Rotes KreuzÄrzte der Welt